BIS icon

ProShares UltraShort NASDAQ Biotechnology
BIS

Overview Fund Trends Analyst Outlook Journalist POV

6 hedge funds and large institutions have $1.26M invested in ProShares UltraShort NASDAQ Biotechnology in 2021 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more ownership

Funds ownership: →

less funds holding

Funds holding: →

less capital invested

Capital invested by funds: $ → $

50% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 2

Holders
6
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$239K
2
+$221K
3
+$29.2K
4
Morgan Stanley
Morgan Stanley
New York
+$3K

Top Sellers

1
-$556K
2
-$237K
3
-$20K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$495K
2
$388K
3
$317K
4
$55K
5
$3K
6
$2K
7
–
8
–